Cargando…

Obesity Affects the Biopsy-Mediated Detection of Prostate Cancer, Particularly High-Grade Prostate Cancer: A Dose-Response Meta-Analysis of 29,464 Patients

BACKGROUND AND OBJECTIVES: In previous studies, obesity (measured according to the body mass index) has correlated inconsistently with the risk of biopsy-measured prostate cancer, and specifically high-grade prostate cancer. This meta-analysis aimed to clarify these correlations. METHODS: A comprehe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Meng-Bo, Liu, Sheng-Hua, Jiang, Hao-Wen, Bai, Pei-De, Ding, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153672/ https://www.ncbi.nlm.nih.gov/pubmed/25184215 http://dx.doi.org/10.1371/journal.pone.0106677

Ejemplares similares

Comprehensive Analysis of 29,464 Cancer Cases and 35,858 Controls to Investigate the Effect of the Cytotoxic T-Lymphocyte Antigen 4 Gene rs231775 A/G Polymorphism on Cancer Risk
por: Wan, Hongyuan, et al.
Publicado: (2022)

The percentage of high‐grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death
por: Berney, Daniel M, et al.
Publicado: (2019)

Identification of Urine Biomarkers to Improve Eligibility for Prostate Biopsy and Detect High-Grade Prostate Cancer
por: Alijaj, Nagjie, et al.
Publicado: (2022)

COMPARISON OF GRADING ACCURACY OF PROSTATE CANCER IN SAMPLES ACQUIRED BY A TARGETED AND SYSTEMIC PROSTATE BIOPSY
por: Pezelj, Ivan, et al.
Publicado: (2022)

A Nomogram Based on a TRUS Five-Grade Scoring System for the Prediction of Prostate Cancer and High Grade Prostate Cancer at Initial TRUS-Guided Biopsy
por: Xie, Shao Wei, et al.
Publicado: (2018)

Strain Elastography-Targeted Biopsy: Does Prostate Volume Affect Prostate Cancer Detection?
por: Zhu, Yi-Cheng, et al.
Publicado: (2019)

The impact of metformin use on the risk of prostate cancer after prostate biopsy in patients with high grade intraepithelial neoplasia
por: Dell'Atti, Lucio, et al.
Publicado: (2018)

Clinical analysis of EV‐Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy
por: Fairey, Adrian, et al.
Publicado: (2023)

Association between obesity and frequency of high-grade prostate cancer on biopsy in men: A single-center retrospective study
por: Baio, Raffaele, et al.
Publicado: (2022)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
por: Alkema, Nicolette G., et al.
Publicado: (2022)

Case Report: High-grade anterior prostate cancer previously undetected by transrectal biopsy, diagnosed with MRI-US fusion transperineal robotic prostate biopsy
por: Harsanto, Andrian, et al.
Publicado: (2022)

Atypical Small Acinar Proliferation: Repeat Biopsy and Detection of High Grade Prostate Cancer
por: Leone, Andrew, et al.
Publicado: (2015)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
por: Lee, Kwang Suk, et al.
Publicado: (2017)

Can expressed prostatic secretions affect prostate biopsy decision of urologist?
por: Ergün, Osman, et al.
Publicado: (2019)

ERG expression in prostate cancer biopsies with and without high-grade prostatic intraepithelial neoplasia: a study in Jordanian Arab patients
por: Aldaoud, Najla, et al.
Publicado: (2019)

Significance of Atypical Small Acinar Proliferation and High-Grade Prostatic Intraepithelial Neoplasia in Prostate Biopsy
por: Koca, Orhan, et al.
Publicado: (2011)

Outcomes and Trends of Prostate Biopsy for Prostate Cancer in Chinese Men from 2003 to 2011
por: Na, Rong, et al.
Publicado: (2012)

Gleason grading of prostate cancer in needle core biopsies: a comparison of general and urologic pathologists
por: Al-Maghrabi, Jaudah Ahmed, et al.
Publicado: (2013)

Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer
por: Mori, Keiichiro, et al.
Publicado: (2021)

A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy
por: McKiernan, James, et al.
Publicado: (2020)

Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer
por: Maity, Sankar N., et al.
Publicado: (2016)

Using the Method of “Optical Biopsy” of Prostatic Tissue to Diagnose Prostate Cancer
por: Artemyev, Dmitry N., et al.
Publicado: (2021)

The Prostate Cancer Detection Rate on the Second Prostate Biopsy according to Prostate-Specific Antigen Trend
por: Kim, Hyung-Sang, et al.
Publicado: (2012)

Paradigm Shift in Prostate Cancer Diagnosis: Pre-Biopsy Prostate Magnetic Resonance Imaging and Targeted Biopsy
por: Park, Jung Jae, et al.
Publicado: (2022)

Neuroendocrine Differentiation In Prostate Adenocarcinoma Biopsies And Its Correlation To Histological Grading
por: Marcu, Mădălina, et al.
Publicado: (2010)

Prostate Cancer in Patients with Metabolic Syndrome Is Associated with Low Grade Gleason Score When Diagnosed on Biopsy
por: Jeon, Kyoung Pil, et al.
Publicado: (2012)

Risk score predicts high‐grade prostate cancer in DNA‐methylation positive, histopathologically negative biopsies
por: Van Neste, Leander, et al.
Publicado: (2016)

Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens
por: Nagpal, Kunal, et al.
Publicado: (2020)

Characterization of prostate cancer detected at repeat biopsy
por: Yuasa, Takeshi, et al.
Publicado: (2008)

Liquid Biopsy Potential Biomarkers in Prostate Cancer
por: Neuhaus, Jochen, et al.
Publicado: (2018)

Higher Body Mass Index Increases the Risk for Biopsy-Mediated Detection of Prostate Cancer in Chinese Men
por: Hu, Meng-Bo, et al.
Publicado: (2015)

Step-by-Step: Fusion-guided prostate biopsy in the diagnosis and surveillance of prostate cancer
por: Nassiri, Nima, et al.
Publicado: (2019)

Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification
por: Davik, Petter, et al.
Publicado: (2022)

Is Prostate Biopsy Essential to Diagnose Prostate Cancer in the Older Patient with Extremely High Prostate-Specific Antigen?
por: Jang, Jee Young, et al.
Publicado: (2012)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
por: Park, Yong Hyun, et al.
Publicado: (2014)

Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?
por: Kim, Sang Jin, et al.
Publicado: (2015)

The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
por: Xiang, Yu-zhu, et al.
Publicado: (2013)

Comparison of a Personalized Prostate Biopsy Pattern With Traditional Transrectal Prostate Biopsy: Different Cancer Detection Rate
por: Jiang, Xin, et al.
Publicado: (2022)

Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsy
por: Sun, Chuanyu, et al.
Publicado: (2011)

464 A Novel High Dose Rate Brachytherapy Device for Preventing Local Recurrence of Pancreatic Cancer Dosimetry Verification
por: Verma, Rohan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fhl1ken10iuhvtjb3s1eqn295k